% | $
Quotes you view appear here for quick access.

SPDR S&P 500 ETF Message Board

carlwilliams_2001 1 post  |  Last Activity: Aug 6, 2015 5:37 PM Member since: Dec 22, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • carlwilliams_2001 by carlwilliams_2001 Aug 6, 2015 5:37 PM Flag

    Dennis Goldberg, Ph.D., President of LipimetiX, stated: "We believe that the profound cholesterol lowering effect of a single injection of AEM-28-14, accompanied by the enhanced toleration, will allow us to expand upon the statistically-significant VLDL cholesterol and triglyceride reductions seen in our recently completed AEM-28 human clinical studies. Subject to funding, the JV plans to begin development of AEM-28-14 for cholesterol and triglyceride reduction in patients refractory to available therapeutic modalities."
    Check CAPS

201.21+1.80(+0.90%)Oct 8 4:25 PMEDT